PALB2 mutations in German and Russian patients with bilateral breast cancer

Breast Cancer Research and Treatment

Volumn 126, Issue 2, 2011, Pages 545-550

  Bogdanova, Natalia ^a   Sokolenko, Anna P ^b,c   Iyevleva, Aglaya G ^b,c   Abysheva, Svetlana N ^b   Blaut, Magda ^a   Bremer, Michael ^a   Christiansen, Hans ^d   Rave Fränk, Margret ^d   Dörk, Thilo ^a   Imyanitov, Evgeny N ^b,c,e  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

^c SAINT PETERSBURG STATE PEDIATRIC MEDICAL UNIVERSITY   (Russian Federation)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^e St Petersburg Medical Academy for Postgraduate Studies   (Russian Federation)

Author keywords

Breast cancer; High resolution melting; Mutation; PALB2; Review

Indexed keywords

GENOMIC DNA; PARTNER AND LOCALIZER OF BRCA2 PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BILATERAL BREAST CANCER; BILATERAL CANCER; BREAST CANCER; BREAST CARCINOGENESIS; CANCER PATIENT; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; FRAMESHIFT MUTATION; GENE MUTATION; GENETIC ANALYSIS; GERM LINE; GERMANY; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR PATHOLOGY; NONSENSE MUTATION; PARTNER AND LOCALIZER OF BRCA2 GENE; PRIORITY JOURNAL; RUSSIAN FEDERATION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CODON, NONSENSE; FEMALE; FRAMESHIFT MUTATION; GERM-LINE MUTATION; GERMANY; HUMANS; MIDDLE AGED; MUTATION, MISSENSE; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RUSSIA; TUMOR SUPPRESSOR PROTEINS;

EID: 79958732548     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1290-4     Document Type: Article

References (32)

1. Fackenthal JD, Olopade OI (2007) Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer 7:937-948 (Pubitemid 350165853)
2. Turnbull C, Rahman N (2008) Genetic predisposition to breast cancer: past, present, and future. Annu Rev Genomics Hum Genet 9:321-345
3. Kurian AW (2010) BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications. Curr Opin Obstet Gynecol 22:72-78
4. Walsh T, King MC (2007) Ten genes for inherited breast cancer. Cancer Cell 11:103-105 (Pubitemid 46209856)
5. Tischkowitz M, Xia B (2010) PALB2/FANCN: Recombining cancer and Fanconi anemia. Cancer Res 70:7353-7359
6. Erkko H, Xia B, Nikkilä J, Schleutker J, Syrjäkoski K, Mannermaa A, Kallioniemi A, Pylkäs K, Karppinen SM, Rapakko K, Miron A, Sheng Q, Li G, Mattila H, Bell DW, Haber DA, Grip M, Reiman M, Jukkola-Vuorinen A, Mustonen A, Kere J, Aaltonen LA, Kosma VM, Kataja V, Soini Y, Drapkin RI, Livingston DM, Winqvist R (2007) A recurrent mutation in PALB2 in Finnish cancer families. Nature 446:316-319 (Pubitemid 46426155)
7. Heikkinen T, Kärkkäinen H, Aaltonen K, Milne RL, Heikkilä P, Aittomäki K, Blomqvist C, Nevanlinna H (2009) The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype. Clin Cancer Res 15: 3214-3222
8. Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, Reid S, Spanova K, Barfoot R, Chagtai T, Jayatilake H, McGuffog L, Hanks S, Evans DG, Eccles D, Breast Cancer Susceptibility Collaboration (UK), Easton DF, Stratton MR (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 39:165-167 (Pubitemid 46184346)
9. Tischkowitz M, Xia B, Sabbaghian N, Reis-Filho JS, Hamel N, Li G, van Beers EH, Li L, Khalil T, Quenneville LA, Omeroglu A, Poll A, Lepage P, Wong N, Nederlof PM, Ashworth A, Tonin PN, Narod SA, Livingston DM, Foulkes WD (2007) Analysis of PALB2/FANCN-associated breast cancer families. Proc Natl Acad Sci USA 104:6788-6793 (Pubitemid 47175579)
10. Foulkes WD, Ghadirian P, Akbari MR, Hamel N, Giroux S, Sabbaghian N, Darnel A, Royer R, Poll A, Fafard E, Robidoux A, Martin G, Bismar TA, Tischkowitz M, Rousseau F, Narod SA (2007) Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women. Breast Cancer Res 9:R83
11. Cao AY, Huang J, Hu Z, Li WF, Ma ZL, Tang LL, Zhang B, Su FX, Zhou J, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Yuan WT, Shen ZZ, Huang W, Shao ZM (2009) The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives. Breast Cancer Res Treat 114:457-462
12. García MJ, Fernández V, Osorio A, Barroso A, Fernández F, Urioste M, Benítez J (2009) Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition. Carcinogenesis 30:1898-1902
13. Sluiter M, Mew S, van Rensburg EJ (2009) PALB2 sequence variants in young South African breast cancer patients. Fam Cancer 8:347-353
14. Adank MA, van Mil SE, Gille JJP, Waisfisz Q, Meijers-Heijboer H (2010) PALB2 analysis in BRCA2-like families. Breast Cancer Res Treat. doi:10.1007/s10549-010-1001-1
15. Balia C, Sensi E, Lombardi G, Roncella M, Bevilacqua G, Caligo MA (2010) PALB2: a novel inactivating mutation in an Italian breast cancer family. Fam Cancer 9:531-536
16. Ding YC, Steele L, Kuan C-J, Greilac S, Neuhausen SL (2010) Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States. Breast Cancer Res Treat. doi:10.1007/s10549-010-1195-2
17. Papi L, Putignano AL, Congregati C, Piaceri I, Zanna I, Sera F, Morrone D, Genuardi M, Palli D (2010) A PALB2 germline mutation associated with hereditary breast cancer in Italy. Fam Cancer 9:181-185
18. Jones S, Hruban RH, Kamiyama M, Borges M, Zhang X, Parsons DW, Lin JC, Palmisano E, Brune K, Jaffee EM, Iacobuzio-Donahue CA, Maitra A, Parmigiani G, Kern SE, Velculescu VE, Kinzler KW, Vogelstein B, Eshleman JR, Goggins M, Klein AP (2009) Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science 324:217
19. Tischkowitz MD, Sabbaghian N, Hamel N, Borgida A, Rosner C, Taherian N, Srivastava A, Holter S, Rothenmund H, Ghadirian P, Foulkes WD, Gallinger S (2009) Analysis of the gene coding for the BRCA2-interacting protein PALB2 in familial and sporadic pancreatic cancer. Gastroenterology 137:1183-1186
20. Slater EP, Langer P, Niemczyk E, Strauch K, Butler J, Habbe N, Neoptolemos J, Greenhalf W, Bartsch DK (2010) PALB2 mutations in European familial pancreatic cancer families. Clin Genet 78:490-494
21. Dansonka-Mieszkowska A, Kluska A, Moes J, Dabrowska M, Nowakowska D, Niwinska A, Derlatka P, Cendrowski K, Kupryjanczyk J (2010) A novel germline PALB2 deletion in Polish breast and ovarian cancer patients. BMC Med Genet 11:20
22. Reid S, Schindler D, Hanenberg H, Barker K, Hanks S, Kalb R, Neveling K, Kelly P, Seal S, Freund M, Wurm M, Batish SD, Lach FP, Yetgin S, Neitzel H, Ariffin H, Tischkowitz M, Mathew CG, Auerbach AD, Rahman N (2007) Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet 39:162-164 (Pubitemid 46184345)
23. Xia B, Dorsman JC, Ameziane N, de Vries Y, Rooimans MA, Sheng Q, Pals G, Errami A, Gluckman E, Llera J, Wang W, Livingston DM, Joenje H, de Winter JP (2007) Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat Genet 39:159-161 (Pubitemid 46184344)
24. Gunnarsson H, Arason A, Gillanders EM, Agnarsson BA, Johannesdottir G, Johannsson OT, Barkardottir RB (2008) Evidence against PALB2 involvement in Icelandic breast cancer susceptibility. J Negat Results Biomed 7:5
25. Guénard F, Pedneault CS, Ouellette G, Labrie Y, Simard J, Durocher F (2010) Evaluation of the contribution of the three breast cancer susceptibility genes CHEK2, STK11, and PALB2 in non-BRCA1/2 French Canadian families with high risk of breast cancer. Genet Test Mol Biomarkers 14:515-526
26. McInerney NM, Miller N, Rowan A, Colleran G, Barclay E, Curran C, Kerin MJ, Tomlinson IP, Sawyer E (2010) Evaluation of variants in the CHEK2, BRIP1 and PALB2 genes in an Irish breast cancer cohort. Breast Cancer Res Treat 121:203-210
27. de Sauty Chalon A, Teo Z, Park DJ, Odefrey FA, kConFab, Hopper JL, Southey MC (2010) Are PALB2 mutations associated with increased risk of male breast cancer? Breast Cancer Res Treat 121:253-255
28. Antoniou AC, Easton DF (2003) Polygenic inheritance of breast cancer: Implications for design of association studies. Genet Epidemiol 25:190-202 (Pubitemid 37296594)
29. Imyanitov EN, Cornelisse CJ, Devilee P (2007) Searching for susceptibility alleles: emphasis on bilateral breast cancer. Int J Cancer 121:921-923 (Pubitemid 47106227)
30. Fletcher O, Johnson N, Dos Santos Silva I, Kilpivaara O, Aittomäki K, Blomqvist C, Nevanlinna H, Wasielewski M, Meijers-Heijerboer H, Broeks A, Schmidt MK, Van't Veer LJ, Bremer M, Dörk T, Chekmariova EV, Sokolenko AP, Imyanitov EN, Hamann U, Rashid MU, Brauch H, Justenhoven C, Ashworth A, Peto J (2009) Family history, genetic testing, and clinical risk prediction: pooled analysis of CHEK2 1100delC in 1, 828 bilateral breast cancers and 7, 030 controls. Cancer Epidemiol Biomarkers Prev 18:230-234
31. Kuligina E, Reiner A, Imyanitov EN, Begg CB (2010) Evaluating cancer epidemiologic risk factors using multiple primary malignancies. Epidemiology 21:366-372
32. Steinmann D, Bremer M, Rades D, Skawran B, Siebrands C, Karstens JH, Dörk T (2001) Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer. Br J Cancer 85(6):850-858 (Pubitemid 33010552)